|
| Status |
Public on May 22, 2021 |
| Title |
Next Generation Sequencing of T6PNE human pancreatic cell with DMSO vs NCT (HNF4a agonist) in palmitate |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
T6PNE human pancreatic cells were treated by DMSO or N-trans caffeoyltyramine (NCT) for 2 days with palmitate, followed by harvesting for RNA isolation.
|
| |
|
| Overall design |
T6PNE cells treated with DMSO or NCT compound in palmitate
|
| |
|
| Contributor(s) |
Levine F |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
May 21, 2021 |
| Last update date |
May 28, 2021 |
| Contact name |
Brian Patrick James |
| E-mail(s) |
bjames@sanfordburnham.org
|
| Organization name |
Sanford Burnham Prebys Medical Discovery Institute
|
| Department |
Genomics
|
| Lab |
James
|
| Street address |
10901 North Torrey Pines Road
|
| City |
San Diego |
| State/province |
CA |
| ZIP/Postal code |
92037 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (2) |
|
| Relations |
| BioProject |
PRJNA731905 |
| SRA |
SRP320870 |
